BioCentury
ARTICLE | Company News

ERBA Diagnostics Mannheim GmbH, Ivax Diagnostics deal

September 13, 2010 7:00 AM UTC

ERBA purchased 72% of the outstanding shares of IVAX for $0.75 per share in cash, or about $15 million. The price is a 36% premium to IVAX's close of $0.55 on Aug. 31, the day before the transaction w...